Largest Clinical Trials companies in the world by Market Capitalization

This ranking features the largest 1,492 Clinical Trials companies in the world ranked by Market Capitalization, totaling a Market Capitalization of USD 7.03 T, for July 08, 2025.

#	Name	Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue Revenue Year-on-Year (YoY) growth Operating Income EBIT EBITDA Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

…

Frequently Asked Questions

Which Clinical Trials company in the world has the highest Market Capitalization ?

The Clinical Trials company in the world with the highest Market Capitalization is Eli Lilly and Company (NYSE: LLY) at USD 700.84 B.

Which Clinical Trials company in the world has the lowest Market Capitalization ?

The Clinical Trials company in the world with the lowest Market Capitalization is EyeGate Pharmaceuticals, Inc. (NasdaqGM: EYEG) at None.

What are the top 10 Clinical Trials companies in the world by Market Capitalization ?

The top 10 Clinical Trials companies in the world by Market Capitalization are Eli Lilly and Company, AbbVie Inc., Novo Nordisk A/S, Roche Holding AG, Novartis AG, Abbott Laboratories, AstraZeneca PLC, Merck & Co., Inc., Thermo Fisher Scientific Inc. and Amgen Inc..

What are the bottom 10 Clinical Trials companies in the world by Market Capitalization ?

The bottom 10 Clinical Trials companies in the world by Market Capitalization are EyeGate Pharmaceuticals, Inc., Nextgen Biomed Ltd, Fluicell AB (publ), NAYA Biosciences, Inc. Common Stock, Aptahem AB (publ), Scinai Immunotherapeutics Ltd., Aptose Biosciences Inc., Qualigen Therapeutics, Inc., Alzamend Neuro, Inc. and Applied DNA Sciences, Inc..